Business Context and Reporting Period
This Form 8-K Current Report, dated June 8, 2020, details a material definitive agreement entered into by Glaukos Corporation (GKOS). The filing announces the issuance of $250 million in aggregate principal amount of 2.75% Convertible Senior Notes due 2027 in a private offering to qualified institutional buyers. The transaction was executed pursuant to an Indenture dated June 11, 2020, with Wells Fargo Bank, National Association, as trustee.
Key Financial Metrics and Transaction Terms
- Principal Amount: $250 million in Convertible Senior Notes, with an option for Initial Purchasers to acquire up to an additional $37.5 million.
- Interest Rate: 2.75% per year, payable semi-annually in arrears beginning December 15, 2020.
- Maturity Date: June 15, 2027.
- Conversion Price: Approximately $56.10 per share (initial conversion rate of 17.8269 shares per $1,000 principal amount).
- Stock Price Reference: The conversion price represents a 30.0% premium to the $43.15 per share closing price on June 8, 2020.
- Maximum Dilution: Up to 5,793,725 shares of common stock (or 6,662,784 shares if the additional note option is fully exercised).
- Capped Call Transactions: Entered into to offset potential dilution, with an initial cap price of $86.30 per share (100% premium over the June 8 stock price).
Material Changes and Covenants
The filing represents a significant change in the Company's capital structure through the addition of senior unsecured debt. Key terms regarding changes and covenants include:
- Redemption: The Company may not redeem the Notes prior to June 20, 2024. Thereafter, redemption is permitted if the common stock price exceeds 130% of the conversion price for a specified period.
- Conversion Triggers: Holders may convert prior to March 15, 2027, only under specific circumstances, such as the stock price exceeding 130% of the conversion price during a calendar quarter or if the trading price of the Notes falls below 98% of the product of the stock price and conversion rate.
- Fundamental Change: Holders may require the Company to repurchase the Notes at 100% of the principal amount plus accrued interest if a fundamental change occurs.
- Settlement: Upon conversion, the Company may settle obligations in cash, shares, or a combination of both at its election.
Outlook, Risks, and Contingencies
The filing does not provide specific forward-looking financial guidance or management commentary regarding future revenue or profit projections. However, it outlines several contingencies and risks inherent to the transaction:
- Dilution Risk: While Capped Call Transactions are intended to reduce dilution, the cap price limits the extent of this protection. If the stock price exceeds the cap, the Company may face dilution or cash outflows.
- Market Conditions: The ability to redeem the Notes or the likelihood of conversion is heavily dependent on the future trading price of the Company's common stock relative to the conversion price.
- Liquidity and Debt Service: The Company assumes a new fixed interest obligation of 2.75% annually, impacting future cash flow requirements.
- Unregistered Securities: The Notes and shares issuable upon conversion are unregistered and may not be offered or sold in the U.S. absent registration or an applicable exemption.
Investor Verification Checklist
- Verify the exercise status of the 13-day option for the additional $37.5 million in Notes.
- Review the full text of the Indenture (Exhibit 4.1) and Capped Call Confirmation (Exhibit 10.1) for detailed adjustment mechanisms and default provisions.
- Assess the impact of the new debt on the Company's leverage ratios and liquidity position relative to existing obligations.
- Monitor the Company's stock price performance relative to the $56.10 conversion price and the $86.30 cap price to evaluate potential dilution scenarios.
- Confirm the use of proceeds from the offering, which is not explicitly detailed in this summary text.